WAIVER AGREEMENTWaiver Agreement • March 31st, 1998 • Seragen Inc • Biological products, (no disgnostic substances)
This Waiver Agreement is made as of October 28, 1997, by and between Boston University, Leon C. Hirsch, Turi Josefsen, Gerald S.J. Cassidy and Loretta P. Cassidy (individually, a "Stockholder" and collectively, the "Stockholders"), Reed R. Prior ("Prior"), and Seragen, Inc. (the "Company").
3. Term. This Sublease shall commence on January 1, 1998 and shall continue until January 31, 1999. Subtenant shall have two successive options to extend the term of this Sublease each for a period of one year for the Rent specified in Sections 4 and...Sublease • March 31st, 1998 • Seragen Inc • Biological products, (no disgnostic substances) • Massachusetts
WAIVER Reference is made to the Amended and Restated Employment Agreement dated as of September 22, 1997 between Seragen, Inc. (the "Company") and the undersigned (the "Agreement"). Pursuant to the Agreement, the Company agreed to file on or before...Employment Agreement • March 31st, 1998 • Seragen Inc • Biological products, (no disgnostic substances)
Reference is made to the Amended and Restated Employment Agreement dated as of September 22, 1997 between Seragen, Inc. (the "Company") and the undersigned (the "Agreement"). Pursuant to the Agreement, the Company agreed to file on or before December 31, 1997, a registration statement on Form S-8 (the "Registration Statement") registering under the Securities Act of 1993 all shares issued or to be issued pursuant to the exercise of the stock options granted to Dr. Nichols pursuant to the Agreement.
WAIVER NO. 5 Reference is made to the Employment Agreement dated as of November 6, 1996 between Seragen, Inc. (the "Company") and the undersigned, as amended (collectively the "Agreement"). Pursuant to the Agreement and subsequent waivers, the Company...Seragen Inc • March 31st, 1998 • Biological products, (no disgnostic substances)
Reference is made to the Employment Agreement dated as of November 6, 1996 between Seragen, Inc. (the "Company") and the undersigned, as amended (collectively the "Agreement"). Pursuant to the Agreement and subsequent waivers, the Company agreed to file on or before December 31, 1997, a registration statement on Form S-8 (the "Registration Statement") registering under the Securities Act of 1993 all shares issued or to be issued pursuant to the exercise of the stock options granted to Mr. Prior pursuant to the Agreement.
AMENDMENT NO. 5 CONSULTING AGREEMENT This Amendment, effective as of January 1, 1998, is made by and between Seragen, Inc., a Delaware corporation having an address at 97 South Street, Hopkinton, Massachusetts ("Seragen") and John R. Murphy, Ph.D.,...Consulting Agreement • March 31st, 1998 • Seragen Inc • Biological products, (no disgnostic substances)
ASSIGNMENT OF SUBLEASE AND AGREEMENT THIS ASSIGNMENT OF SUBLEASE AND AGREEMENT (the "Agreement") is made this 31st day of December, 1997 by and among SERAGEN, INC., a Delaware corporation having a principal place of business at 97 South Street,...Assignment of Sublease and Agreement • March 31st, 1998 • Seragen Inc • Biological products, (no disgnostic substances) • Massachusetts
ASSIGNMENT OF LEASE AND AGREEMENT THIS ASSIGNMENT OF LEASE AND AGREEMENT (the "Agreement") is made this 31st day of December 1997 by and among SERAGEN, INC., a Delaware corporation having a principal place of business at 97 South Street, Hopkinton,...Assignment of Lease and Agreement • March 31st, 1998 • Seragen Inc • Biological products, (no disgnostic substances) • Massachusetts
3. Term. This Second Sublease shall commence on January 1, 1998 and shall continue until January 31, 1999. Second Subtenant shall have two successive options to extend the term of this Second Sublease each for a period of one year for the Rent...Second Sublease • March 31st, 1998 • Seragen Inc • Biological products, (no disgnostic substances) • Massachusetts
